Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_assertion type Assertion NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_head.
- NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_assertion description "[The purposes of this study were to evaluate the tolerance, efficacy and safety of isovolemic erythrocytapheresis (EA) in nonanemic patients with hereditary hemochromatosis (HH), and to assess the usefulness of recombinant human erythropoietin (rHuEPO) associated with EA to reduce treatment duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_provenance.
- NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_assertion evidence source_evidence_literature NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_provenance.
- NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_assertion SIO_000772 10971213 NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_provenance.
- NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_assertion wasDerivedFrom befree-20140225 NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_provenance.
- NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_assertion wasGeneratedBy ECO_0000203 NP938478.RAIluFF0IdonZhhSS9wSG1jb8Th9BllO7oUbPQXjjFriA130_provenance.